---
figid: PMC7699465__cancers-12-03437-g001
figtitle: ' Nelfinavir inhibits the Nrf1-dependent synthesis of proteasome subunits
  and inhibits the proteasome, leading to accumulation of misfolded proteins that
  activate IRE1A and PERK arms of the UPR'
organisms:
- Human immunodeficiency virus 1
- Human immunodeficiency virus
- Human papillomavirus
- Tomato blistering mosaic virus
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
pmcid: PMC7699465
filename: cancers-12-03437-g001.jpg
figlink: pmc/articles/PMC7699465/figure/cancers-12-03437-f001/
number: F1
caption: (A) Nelfinavir inhibits the Nrf1-dependent synthesis of proteasome subunits
  and inhibits the proteasome, leading to accumulation of misfolded proteins that
  activate IRE1α and PERK arms of the UPR. PERK activation leads to modulation of
  protein synthesis and cell death. Nelfinavir also inhibits S2P in the Golgi apparatus
  causing accumulation of un-cleaved ATF6 and SREBP. (B) Nelfinavir activates autophagy
  by inhibiting mTOR and by activating eEF2K; however, nelfinavir-mediated inhibition
  of calpain may impair autophagy as well. (C) Nelfinavir can inhibit HSP90 and its
  interaction with client proteins Akt, RET and HSP70. Nelfinavir can also cause inhibition
  of P-gp efflux pump and receptor protein tyrosine kinase (RPTK). Inhibition of the
  PI3K–Akt pathway leads to inhibition of VEGF hindering angiogenesis. (D) Nelfinavir
  inhibits phosphatase CReP, STAT3, MMP-2/9, and the SMAD2 pathway. (E) Nelfinavir
  promotes DNA damage and can lead to cell cycle arrest by modulating components of
  cell cycle. (F) Nelfinavir increases the expression of DR4/5 to enhance TRAIL sensitivity
  and activates the extrinsic apoptotic pathway. Nelfinavir also inhibits the MAPK
  pathway. (G) Nelfinavir decreases the mitochondrial membrane potential and activates
  the intrinsic apoptotic cascade. Nelfinavir also inhibits glutathione to increase
  the production of ROS, leading to cell cycle arrest. Nelfinavir-mediated translocation
  of the apoptosis-inducing factor (AIF) from the mitochondria to the nucleus contributes
  to cell death. (H) Nelfinavir inhibits the expression of anti-apoptotic proteins
  facilitating apoptosis and contributing to caspase-independent cell death.
papertitle: The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir.
reftext: Mahbuba R. Subeha, et al. Cancers (Basel). 2020 Nov;12(11):3437.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9012899
figid_alias: PMC7699465__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7699465__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7699465__cancers-12-03437-g001.html
  '@type': Dataset
  description: (A) Nelfinavir inhibits the Nrf1-dependent synthesis of proteasome
    subunits and inhibits the proteasome, leading to accumulation of misfolded proteins
    that activate IRE1α and PERK arms of the UPR. PERK activation leads to modulation
    of protein synthesis and cell death. Nelfinavir also inhibits S2P in the Golgi
    apparatus causing accumulation of un-cleaved ATF6 and SREBP. (B) Nelfinavir activates
    autophagy by inhibiting mTOR and by activating eEF2K; however, nelfinavir-mediated
    inhibition of calpain may impair autophagy as well. (C) Nelfinavir can inhibit
    HSP90 and its interaction with client proteins Akt, RET and HSP70. Nelfinavir
    can also cause inhibition of P-gp efflux pump and receptor protein tyrosine kinase
    (RPTK). Inhibition of the PI3K–Akt pathway leads to inhibition of VEGF hindering
    angiogenesis. (D) Nelfinavir inhibits phosphatase CReP, STAT3, MMP-2/9, and the
    SMAD2 pathway. (E) Nelfinavir promotes DNA damage and can lead to cell cycle arrest
    by modulating components of cell cycle. (F) Nelfinavir increases the expression
    of DR4/5 to enhance TRAIL sensitivity and activates the extrinsic apoptotic pathway.
    Nelfinavir also inhibits the MAPK pathway. (G) Nelfinavir decreases the mitochondrial
    membrane potential and activates the intrinsic apoptotic cascade. Nelfinavir also
    inhibits glutathione to increase the production of ROS, leading to cell cycle
    arrest. Nelfinavir-mediated translocation of the apoptosis-inducing factor (AIF)
    from the mitochondria to the nucleus contributes to cell death. (H) Nelfinavir
    inhibits the expression of anti-apoptotic proteins facilitating apoptosis and
    contributing to caspase-independent cell death.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnfsf10
  - Srpx
  - Slc26a3
  - Pik3r1
  - Mdk
  - Nrf1
  - Nfe2l1
  - Hsp90ab1
  - Hsp90aa1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Akt1
  - Mapk3
  - Bak1
  - Pmaip1
  - Hspa1b
  - Akt1s1
  - Hif1a
  - Mdm2
  - Ret
  - Vegfa
  - Srebf1
  - Smad2
  - Eif2ak3
  - Lamp1
  - Ppp1r15b
  - Pxn
  - Atf6
  - Stat3
  - Mmp2
  - Mitf
  - Tff3
  - Naip3
  - Mmp9
  - Ppp1cc
  - Npy4r
  - Eif2a
  - Eif2s1
  - Casp9
  - Aifm1
  - Xbp1
  - Atf4
  - Ppp1r15a
  - Bcl2
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Ddit3
  - Sesn2
  - Trib3
  - Trp53
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Mtor
  - Cdk2
  - Cdc25a
  - Pcna
  - Gabrg2
  - TNFSF10
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - PNN
  - SRPX
  - SLC26A3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - NRF1
  - NFE2L1
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MBTPS2
  - BAK1
  - PMAIP1
  - HSPA1A
  - HSPA4
  - AKT1S1
  - HIF1A
  - MDM2
  - FOXG1
  - FOXH1
  - FOXM1
  - FOXQ1
  - FOXS1
  - FOXA1
  - FOXA2
  - FOXA3
  - FOXB1
  - FOXB2
  - FOXC1
  - FOXC2
  - FOXD1
  - FOXD2
  - FOXD3
  - FOXD4
  - FOXE1
  - FOXE3
  - FOXF1
  - FOXF2
  - FOXI1
  - FOXI2
  - FOXI3
  - FOXJ1
  - FOXJ2
  - FOXJ3
  - FOXK1
  - FOXK2
  - FOXL1
  - FOXL2
  - FOXN1
  - FOXN2
  - FOXN3
  - FOXN4
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - FOXP1
  - FOXP2
  - FOXP3
  - FOXP4
  - FOXR1
  - FOXR2
  - FOXD4L1
  - FOXD4L3
  - FOXD4L4
  - FOXD4L5
  - FOXD4L6
  - RET
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - SREBF1
  - SMAD2
  - EIF2AK3
  - PPP1R15B
  - ATF6
  - STAT3
  - MMP2
  - MITF
  - MMP9
  - PPA1
  - NPY4R
  - NPY4R2
  - EIF2A
  - EIF2S1
  - AIFM1
  - XBP1
  - ATF4
  - PPP1R15A
  - BCL2
  - CHMP2A
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - DDIT3
  - SESN2
  - TRIB3
  - TP53
  - TP63
  - TP73
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - IFI27
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - MTOR
  - CDK2
  - CDC25A
  - PCNA
  - WARS1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ATP8A2
  - Glutathione
  - ATP
  - Pyruvate
---
